SLEEP APNOEA SYNDROME EFFECTS ON CLINICAL COURSE AND QUALITY OF LIFE IN PATIENTS WITH CORONARY HEART DISEASE
Aim. The sleep apnoea syndrome (SAS) is a widely prevalent but under-studied condition which might aggravate the clinical course of various diseases. This study aimed to assess the influence of SAS on the clinical course of coronary heart disease (CHD) and quality of life (QoL) of CHD patients. Mate...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«FIRMA «SILICEA» LLC
2012-10-01
|
| Series: | Российский кардиологический журнал |
| Subjects: | |
| Online Access: | https://russjcardiol.elpub.ru/jour/article/view/1283 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Aim. The sleep apnoea syndrome (SAS) is a widely prevalent but under-studied condition which might aggravate the clinical course of various diseases. This study aimed to assess the influence of SAS on the clinical course of coronary heart disease (CHD) and quality of life (QoL) of CHD patients. Material and methods. The study included 186 patients with various CHD forms and 24 controls with angiographically confirmed absence of CHD. The patients were divided into groups of effort angina, post-infarction cardiosclerosis without chronic heart failure (CHF), and with Functional Class (FC) II–III CHF (NYHA classification). All participants underwent cardiorespiratory monitoring and QoL assessment (WHOQOL-BREF and SAQL questionnaires). Based on the SAS severity, two subgroups with low (0–10 per hour) and high (11–30 per hour) index of apnoeahypopnoea (AHI) were defined. Results. SAS affected the clinical course and QoL to the greatest extent in patients with CHF. Among effort angina patients, this effect was weaker, while no negative impact of SAS was registered in patients with post-infarction cardiosclerosis without CHF. Conclusion. The management of CHD patients should incorporate the screening for possible SAS and target SAS, if present, as one of the factors aggravating the clinical course of the main pathology. |
|---|---|
| ISSN: | 1560-4071 2618-7620 |